title: Pseudo-obstruction secondary to anticholinergic drugs in Parkinson's disease.
authors.forename: L M
authors.initials: LM
authors.lastname: Howard
authors.forename: H
authors.initials: H
authors.lastname: Markus
mesh_terms: D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000139:chemically induced*; D008127:Lofepramine / Q000009:adverse effects*; D008297:Male; D008333:Mandelic Acids / Q000009:adverse effects*; D008875:Middle Aged; D010276:Parasympatholytics / Q000009:adverse effects; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D008333:Mandelic Acids; D010276:Parasympatholytics; C005419:oxybutynin; D008127:Lofepramine